We use the convincing properties of nanobodies to optimise specificity, sensitivity, signal intensity and stability properties of in vitro diagnostic assays (IVD).

The variable domains of heavy chain only antibodies, are by now an established alternative to conventional antibodies for various research questions. Their small size and excellent binding properties are of great advantage for many approaches. Moreover, there are first concepts for medical applications. Nonetheless, the field of medical  in vitro diagnosis of diseases is so far still largely unexploited. This is our starting point.

The first reagents we offer are NanoConjugates, which are designed to detect human IgG, IgM or IgA and surpass conventional animal derived antibody conjugates not only in binding characteristics, but also in reproducibility and price. They are based on a nanobody module directed towards human immunoglobulins and linked to a reporter protein  labelled  with either acridinium or horseradish peroxidase.

Their suitability for diagnostic immuno assays with blood samples is proven and furthermore, we provide an experimental dataset, which characterises their binding properties and confirms their performance for different setups in research and medical diagnosis (for more information see -> NanoConjugates).

Key characterisics of NanoConjugates:

• Specific
• Sensitive
• Intensive signal
• Stable
• Reproducible
• Cost effective
• Free from animal testing